Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in MGNX — Macrogenics Inc

CIK 72971 SAN FRANCISCO, CA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$275,749
+$267,079 QoQ
Shares Held
59,686
+1889.5% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. MGNX ranks #228 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in MGNX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $275,749 59,686
2026-03-31 $8,670 3,000
2025-12-31 $4,830 3,000
2025-09-30 $5,040 3,000
2025-06-30 $626 518
2025-03-31 $38,748 30,511
2024-12-31 $96,973 29,838
2024-09-30 $67,530 20,526
2024-06-30 $89,148 20,976
2024-03-31 $304,821 20,708
2023-12-31 $173,602 18,046
2023-09-30 $67,462 14,477
2023-06-30 $128,324 23,986
2023-03-31 $77,830 10,855
2022-12-31 $1,234 184
2022-09-30 $12,511 3,616
2022-06-30 $12,495 4,236
2022-03-31 $330,947 37,565
2021-12-31 $917,401 57,159
2021-09-30 $1,835,912 87,675
2021-06-30 $2,800,368 104,258
2021-03-31 $4,514,259 141,735
2020-12-31 $3,034,503 132,743
2020-09-30 $1,405,550 55,798
2020-06-30 $1,447,622 51,849
2020-03-31 $259,565 44,599